Charles River Laboratories International (CRL) Other financing activities (2009 - 2025)

Charles River Laboratories International (CRL) has reported Other financing activities for 16 consecutive years, with -$1.3 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other financing activities rose 70.61% year-over-year to -$1.3 million; the TTM figure through Dec 2025 stood at -$14.0 million (up 55.4% YoY), while the FY2025 annual figure was -$14.0 million, up 55.4% from the prior year.
• Other financing activities came in at -$1.3 million for Q4 2025 at Charles River Laboratories International, up from -$6.2 million in the prior quarter.
• The five-year high for Other financing activities was $40.6 million in Q3 2021, with the low at -$15.5 million in Q2 2022.
• Average Other financing activities over 5 years is -$1.3 million, with a median of -$2.3 million recorded in 2021.
• Across the five-year window, Other financing activities plunged 85750.0% in 2022 and surged 70.61% in 2025, its largest moves.
• Year by year, Other financing activities stood at $2000.0 in 2021, then slumped by 85750.0% to -$1.7 million in 2022, then plunged by 141.97% to -$4.1 million in 2023, then retreated by 9.58% to -$4.5 million in 2024, then soared by 70.61% to -$1.3 million in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered -$1.3 million, -$6.2 million, and -$6.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.